There’s no doubt that AI has great potential in life sciences, from R&D through to commercialization. The challenge is seeing through all of the hype. That’s why we’ve gathered some recent articles on this topic that identify specifics regarding what can be done in this emerging field as it pertains to the biopharma industry and what companies have become early adopters.
There’s no doubt that AI has great potential in life sciences, from R&D through to commercialization. The challenge is seeing through all of the hype. That’s why we’ve gathered some recent articles on this topic that identify specifics regarding what can be done in this emerging field as it pertains to the biopharma industry and what companies have become early adopters.
Become better at your biopharma manufacturing job by seeing how some of your peers deal with everything from consent decrees to problems with a CDMO to the need for more engaged employees on the plant floor.
|
|
|
|
|
|
|
|
|